281 related articles for article (PubMed ID: 25216184)
1. Non-laboratory-based self-assessment screening score for non-alcoholic fatty liver disease: development, validation and comparison with other scores.
Lee YH; Bang H; Park YM; Bae JC; Lee BW; Kang ES; Cha BS; Lee HC; Balkau B; Lee WY; Kim DJ
PLoS One; 2014; 9(9):e107584. PubMed ID: 25216184
[TBL] [Abstract][Full Text] [Related]
2. Use of a Diabetes Self-Assessment Score to Predict Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.
Kim G; Lee YH; Park YM; Kim J; Kim H; Lee BW; Kang ES; Cha BS; Lee HC; Kim DJ
Medicine (Baltimore); 2015 Jul; 94(27):e1103. PubMed ID: 26166101
[TBL] [Abstract][Full Text] [Related]
3. What Is the Role of the New Index Relative Fat Mass (RFM) in the Assessment of Nonalcoholic Fatty Liver Disease (NAFLD)?
Machado MV; Policarpo S; Coutinho J; Carvalhana S; Leitão J; Carvalho A; Silva AP; Velasco F; Medeiros I; Alves AC; Bourbon M; Cortez-Pinto H
Obes Surg; 2020 Feb; 30(2):560-568. PubMed ID: 31637670
[TBL] [Abstract][Full Text] [Related]
4. US-FLI score - Is it possible to predict the steatosis grade with an ultrasonographic score?
Xavier SA; Monteiro SO; Arieira CM; Castro FD; Magalhães JT; Leite SM; Marinho CM; Cotter JB
Mol Genet Metab; 2021 Mar; 132(3):204-209. PubMed ID: 33558081
[TBL] [Abstract][Full Text] [Related]
5. Validation of a Non-Laboratory Based Screening Tool for Predicting Non-Alcoholic Fatty Liver Disease in an Egyptian Setting.
Abd El-Wahab EW; Zein El-Abedin RA; Ahmed WM; Shatat HZ
Am J Med Sci; 2020 Dec; 360(6):662-677. PubMed ID: 32739036
[TBL] [Abstract][Full Text] [Related]
6. Cutoff points of abdominal obesity indices in screening for non-alcoholic fatty liver disease in Asians.
Yoo HJ; Park MS; Lee CH; Yang SJ; Kim TN; Lim KI; Kang HJ; Song W; Yeon JE; Baik SH; Choi DS; Choi KM
Liver Int; 2010 Sep; 30(8):1189-96. PubMed ID: 20602679
[TBL] [Abstract][Full Text] [Related]
7. The value of combining the simple anthropometric obesity parameters, Body Mass Index (BMI) and a Body Shape Index (ABSI), to assess the risk of non-alcoholic fatty liver disease.
Kuang M; Sheng G; Hu C; Lu S; Peng N; Zou Y
Lipids Health Dis; 2022 Oct; 21(1):104. PubMed ID: 36266655
[TBL] [Abstract][Full Text] [Related]
8. Non-Laboratory-Based Simple Screening Model for Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Developed Using Multi-Center Cohorts.
Kim J; Lee M; Kim SY; Kim JH; Nam JS; Chun SW; Park SE; Kim KJ; Lee YH; Nam JY; Kang ES
Endocrinol Metab (Seoul); 2021 Aug; 36(4):823-834. PubMed ID: 34474517
[TBL] [Abstract][Full Text] [Related]
9. Fatty liver index vs waist circumference for predicting non-alcoholic fatty liver disease.
Motamed N; Sohrabi M; Ajdarkosh H; Hemmasi G; Maadi M; Sayeedian FS; Pirzad R; Abedi K; Aghapour S; Fallahnezhad M; Zamani F
World J Gastroenterol; 2016 Mar; 22(10):3023-30. PubMed ID: 26973398
[TBL] [Abstract][Full Text] [Related]
10. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
[TBL] [Abstract][Full Text] [Related]
11. Pediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directions.
Clemente MG; Mandato C; Poeta M; Vajro P
World J Gastroenterol; 2016 Sep; 22(36):8078-93. PubMed ID: 27688650
[TBL] [Abstract][Full Text] [Related]
12. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
[TBL] [Abstract][Full Text] [Related]
13. Associations of serum uric acid levels and anthropometric parameters with non-alcoholic fatty liver disease in healthy individuals: innovative insights from a cross-sectional study.
Aydin A; Goktas Aydin S
Curr Med Res Opin; 2024 Feb; 40(2):209-215. PubMed ID: 38111962
[TBL] [Abstract][Full Text] [Related]
14. Waist-to-calf circumstance ratio is an independent predictor of hepatic steatosis and fibrosis in patients with type 2 diabetes.
Choe EY; Lee YH; Choi YJ; Huh BW; Lee BW; Kim SK; Kang ES; Cha BS; Lee EJ; Huh KB; Younossi ZM
J Gastroenterol Hepatol; 2018 May; 33(5):1082-1091. PubMed ID: 28990251
[TBL] [Abstract][Full Text] [Related]
15. Cholecystectomy is independently associated with nonalcoholic fatty liver disease in an Asian population.
Kwak MS; Kim D; Chung GE; Kim W; Kim YJ; Yoon JH
World J Gastroenterol; 2015 May; 21(20):6287-95. PubMed ID: 26034364
[TBL] [Abstract][Full Text] [Related]
16. Pediatric obesity-related non-alcoholic fatty liver disease: waist-to-height ratio best anthropometrical predictor.
Umano GR; Grandone A; Di Sessa A; Cozzolino D; Pedullà M; Marzuillo P; Del Giudice EM
Pediatr Res; 2021 Jul; 90(1):166-170. PubMed ID: 33038873
[TBL] [Abstract][Full Text] [Related]
17. Regional anthropometric measures associated with the severity of liver injury in patients with non-alcoholic fatty liver disease.
Subramanian V; Johnston RD; Kaye P; Aithal GP
Aliment Pharmacol Ther; 2013 Feb; 37(4):455-63. PubMed ID: 23293873
[TBL] [Abstract][Full Text] [Related]
18. Comparison of fatty liver index with noninvasive methods for steatosis detection and quantification.
Zelber-Sagi S; Webb M; Assy N; Blendis L; Yeshua H; Leshno M; Ratziu V; Halpern Z; Oren R; Santo E
World J Gastroenterol; 2013 Jan; 19(1):57-64. PubMed ID: 23326163
[TBL] [Abstract][Full Text] [Related]
19. Sarcopaenia is associated with NAFLD independently of obesity and insulin resistance: Nationwide surveys (KNHANES 2008-2011).
Lee YH; Jung KS; Kim SU; Yoon HJ; Yun YJ; Lee BW; Kang ES; Han KH; Lee HC; Cha BS
J Hepatol; 2015 Aug; 63(2):486-93. PubMed ID: 25772036
[TBL] [Abstract][Full Text] [Related]
20. FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study.
Newsome PN; Sasso M; Deeks JJ; Paredes A; Boursier J; Chan WK; Yilmaz Y; Czernichow S; Zheng MH; Wong VW; Allison M; Tsochatzis E; Anstee QM; Sheridan DA; Eddowes PJ; Guha IN; Cobbold JF; Paradis V; Bedossa P; Miette V; Fournier-Poizat C; Sandrin L; Harrison SA
Lancet Gastroenterol Hepatol; 2020 Apr; 5(4):362-373. PubMed ID: 32027858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
